We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Surgical System with Miniaturized and Flexible Robotic Arms Could Be a Game-Changer for Endoluminal Surgery

By HospiMedica International staff writers
Posted on 20 Apr 2023

An innovative endoscopic surgical system, featuring highly miniaturized and flexible robotic arms, has the potential to revolutionize endoluminal surgery for both medical practitioners and patients.

The endoscopic surgery system from Agilis Robotics (Science Park, Hong Kong) boasts a unique combination of features that distinguish it from traditional surgical robotic systems. With its compact design and user-friendly interface, which requires minimal training, this cutting-edge surgical system is set to transform the realm of minimally invasive surgeries. One of the system's most notable attributes is its extraordinary flexibility. Offering five degrees of freedom per arm and a completely flexible body, it enables surgeons to perform intricate tissue resection procedures with remarkable precision and ease within natural orifices. This exceptional maneuverability, combined with its intuitive control interface and artificial intelligence support, is invaluable in endoscopic surgery, where skillful manipulation of surgical instruments is extremely difficult without robotic assistance.


Image: Live swine trial of the surgical robotic arms that can transform endoscopic surgery (Photo courtesy of Agilis)
Image: Live swine trial of the surgical robotic arms that can transform endoscopic surgery (Photo courtesy of Agilis)

Agilis recently demonstrated the system's capabilities in a trial using a live pig subject, successfully performing endoscopic submucosal dissection (ESD) in the upper and lower gastrointestinal tract with the robotic system. Additionally, an endoscopic ex-vivo trial on tracheal tissue was conducted, in which tissue from the trachea was successfully dissected, further showcasing the system's versatility and adaptability across various surgical scenarios.With these encouraging results, Agilis is now targeting FDA 510(k) clearance by 2025. This clearance would enable the company to market its robotic system and make a significant impact in the field of endoscopic surgery.

Related Links:
Agilis Robotics 


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
X-ray Diagnostic System
FDX Visionary-A
New
Mattress Replacement System
Carilex DualPlus

Latest Surgical Techniques News

Endoscopic Surgical System Enables Remote Robot-Assisted Laparoscopic Hysterectomy

Novel Neural Interface to Help Diagnose and Treat Neurological Disorders with Minimal Surgical Risks

New Lens System for Endoscopes Offers Physicians Unprecedented View of Inside the Body